This 2014 review article examines the role of testosterone supplementation therapy (TST) in men with metabolic syndrome (MetS). MetS is characterized by a cluster of conditions including increased waist circumference, high triglyceride levels, low HDL cholesterol, high blood pressure, and insulin resistance, which collectively elevate the risk of type 2
